UroPharma is moving rapidly to commercialisation. The science and momentum are with us.

We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified.

If you want to be part of this journey or to discuss a proposed investment, please contact us.

The commercial opportunities are substantial and the clinical benefits to patients could be life changing.

As evidence mounts of the substantial risks to patients produced by the oral delivery of medicines to combat bladder conditions UroPharma has designed a unique, patented, direct to bladder delivery system. The dtb-instilla is expected to fundamentally change clinical practice.